These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 22192935)
1. [Kidney involvement in mixed cryoglobulinemia: which treatment?]. Cacoub P Presse Med; 2012 Mar; 41(3 Pt 1):254-9. PubMed ID: 22192935 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies. Garini G; Allegri L; Vaglio A; Buzio C Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus infection and glomerular disease. Fabrizi F; Donato F; Messa P Minerva Urol Nefrol; 2014 Jun; 66(2):139-49. PubMed ID: 24988205 [TBL] [Abstract][Full Text] [Related]
4. The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia. Muro K; Toda N; Yamamoto S; Yanagita M Intern Med; 2021 Feb; 60(4):583-589. PubMed ID: 32999232 [TBL] [Abstract][Full Text] [Related]
5. Treatment of hepatitis C-related kidney disease. Fabrizi F; Martin P; Cacoub P; Messa P; Donato FM Expert Opin Pharmacother; 2015; 16(12):1815-27. PubMed ID: 26161511 [TBL] [Abstract][Full Text] [Related]
6. Long-term remission with rituximab in a patient with severe hepatitis C virus-induced mixed cryoglobulinemia. Fortea-Ormaechea JI; Lozano-Maya M; Adán-Merino L; Barrio-Antoranz J; Martín-Chavarri S; Corchete-Prats E; Martínez-Acebes E; Aldeguer-Martínez M Rev Esp Enferm Dig; 2013 Sep; 105(8):490-3. PubMed ID: 24274448 [TBL] [Abstract][Full Text] [Related]
10. [Successful rituximab therapy of HCV-cryoglobulinemic vasculitis with severe ulcerative and necrotic lesions of the skin]. Ignatova TM; Chernova OA; Gaĭdasheva EV Klin Med (Mosk); 2012; 90(5):64-6. PubMed ID: 22993956 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus-related cryoglobulinemic vasculitis: emerging trends in therapy. St Clair EW Arthritis Rheum; 2012 Mar; 64(3):604-8. PubMed ID: 22147537 [No Abstract] [Full Text] [Related]
12. [Difficulties in treatment of kidney diseases related to HCV infection]. Jabłońska J; Kozłowska J Przegl Epidemiol; 2009; 63(1):75-8. PubMed ID: 19522231 [TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis. Sneller MC; Hu Z; Langford CA Arthritis Rheum; 2012 Mar; 64(3):835-42. PubMed ID: 22147444 [TBL] [Abstract][Full Text] [Related]
14. The dilemma of treating hepatitis C virus-associated cryoglobulinemia. Roccatello D; Fenoglio R; Sciascia S Curr Opin Rheumatol; 2019 Sep; 31(5):499-504. PubMed ID: 31090590 [TBL] [Abstract][Full Text] [Related]
15. [Specific damage to the kidneys in patients with chronic hepatitis C associated with cryoglobulinemia]. Milovanova SIu; Tégaĭ SV; Russkikh AV; Kozlovskaia LV Ter Arkh; 2011; 83(11):38-43. PubMed ID: 22312883 [TBL] [Abstract][Full Text] [Related]